Abstract
The mushroom Ganoderma lucidum (G. lucidum) has been used for centuries in Asian countries to treat various diseases and to promote health and longevity. Clinical studies have shown beneficial effects of G. lucidum as an alternative adjuvant therapy in cancer patients without obvious toxicity. G. lucidum polysaccharides (GLP) is the main bioactive component in the water soluble extracts of this mushroom. Evidence from in vitro and in vivo studies has demonstrated that GLP possesses potential anticancer activity through immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects. Here, we briefly summarize these anticancer effects of GLP and the underlying mechanisms.
Keywords: Ganoderma lucidum polysaccharides, Reishi, anti-cancer, immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic, anti-angiogenic.
Anti-Cancer Agents in Medicinal Chemistry
Title:Ganoderma lucidum Polysaccharides as An Anti-cancer Agent
Volume: 18 Issue: 5
Author(s): Didem Sohretoglu and Shile Huang*
Affiliation:
- Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932,United States
Keywords: Ganoderma lucidum polysaccharides, Reishi, anti-cancer, immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic, anti-angiogenic.
Abstract: The mushroom Ganoderma lucidum (G. lucidum) has been used for centuries in Asian countries to treat various diseases and to promote health and longevity. Clinical studies have shown beneficial effects of G. lucidum as an alternative adjuvant therapy in cancer patients without obvious toxicity. G. lucidum polysaccharides (GLP) is the main bioactive component in the water soluble extracts of this mushroom. Evidence from in vitro and in vivo studies has demonstrated that GLP possesses potential anticancer activity through immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects. Here, we briefly summarize these anticancer effects of GLP and the underlying mechanisms.
Export Options
About this article
Cite this article as:
Sohretoglu Didem and Huang Shile*, Ganoderma lucidum Polysaccharides as An Anti-cancer Agent, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (5) . https://dx.doi.org/10.2174/1871520617666171113121246
DOI https://dx.doi.org/10.2174/1871520617666171113121246 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fatty Acid (FA) Compositions and Trans Content of Frequently Consumed Edible Oils and Fats from Iran’ Market
Current Nutrition & Food Science Editorial: Look for Changes in 2016
Current Molecular Medicine Occupational Respiratory Pathology in Russia: Current Trends and Challenges
Current Respiratory Medicine Reviews The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator
Current Medicinal Chemistry Dermatological, Cardiovascular and Neurological Morphohistopathological Effects of Fluoropyrimidine-based Chemotherapy in Humans
Clinical Cancer Drugs Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity
Current Organic Synthesis Efficacy and Tolerability of Vinorelbine in the Cancer Therapy
Current Drug Safety A Classification Method for Microarrays Based on Diversity
Current Bioinformatics Fatty Acid Profile and In Vitro Anticancer Activity of Two Marine Sponge- Associated Bacteria
Current Bioactive Compounds Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Current Stem Cell Research & Therapy Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications
Anti-Cancer Agents in Medicinal Chemistry Drug Delivery Systems with Modified Release for Systemic and Biophase Bioavailability
Current Clinical Pharmacology Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Silimarin and Cancer
Anti-Cancer Agents in Medicinal Chemistry Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Plant Peptides: Bioactivity, Opportunities and Challenges
Protein & Peptide Letters Lactoferrin: A Biologically Active Molecule for Bone Regeneration
Current Medicinal Chemistry Advances and Challenges in the Development of Therapeutic DNA Vaccines Against Hepatitis B Virus Infection
Current Gene Therapy tcaSIM: A Simulation Program for Optimal Design of 13C Tracer Experiments for Analysis of Metabolic Flux by NMR and Mass Spectroscopy
Current Metabolomics Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition
Current Cancer Drug Targets